AngioDynamics ANGO Balance Sheet Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $37.81M-15.5% | $41.64M-23.0% | $38.76M-29.5% | $55.89M-26.5% | $44.76M-42.9% | ||
| $45.55M+4.8% | $44.43M+3.0% | $42.64M+7.8% | $42.89M-1.7% | $43.47M-12.1% | ||
| $58.58M-7.2% | $65.57M-0.5% | $62.26M-3.8% | $62.01M+2.3% | $63.11M+8.7% | ||
| $13.61M-11.8% | $9.71M-20.4% | $13M-2.5% | $7.54M-41.9% | $15.44M+41.5% | ||
| $155.55M-9.7% | $161.35M-8.0% | $156.66M-9.2% | $168.32M-12.9% | $172.27M-12.5% | ||
| $29.14M-10.4% | $30.53M-7.4% | $31.07M-9.6% | $32.3M-9.4% | $32.53M-12.2% | ||
| $65.49M-7.7% | $66.73M-8.7% | $68.38M-9.8% | $69.12M-10.7% | $70.93M-13.0% | ||
| $10.5M+8.4% | $11.07M+9.6% | $9.54M-12.3% | $10.4M-8.5% | $9.68M+3.8% | ||
| $260.68M-8.7% | $269.68M-7.5% | $265.64M-9.5% | $280.14M-11.8% | $285.42M-12.1% | ||
| $29.11M-3.8% | $35.39M+1.9% | $31.88M+2.0% | $33.29M-11.8% | $30.27M-13.9% | ||
| $4.66M-19.1% | $6.72M-25.1% | $8.74M+34.2% | $7.39M-2.5% | $5.76M-43.9% | ||
| $1.31M-28.1% | $1.31M-30.1% | $1.77M-8.2% | $1.84M-6.8% | $1.83M+11.0% | ||
| —— | —— | —— | $400K— | —— | ||
| $66.07M-15.3% | $71.96M-18.8% | $68.28M-11.0% | $76.2M-16.4% | $77.97M-9.2% | ||
| $2.41M-13.2% | $2.5M— | $2.59M— | $6.2M— | $2.78M— | ||
| $5.49M+24.9% | $5.79M+18.0% | $3.5M-35.5% | $3.95M-33.3% | $4.4M+10.8% | ||
| $2.41M-13.2% | $2.5M— | $2.59M— | $5.8M— | $2.78M— | ||
| $16.7M-3.9% | $17.05M+43.9% | $14.24M-9.4% | $16.9M+5.1% | $17.37M+21.0% | ||
| $87.32M-12.3% | $93.35M-10.9% | $86.79M-10.6% | $97.17M-13.3% | $99.55M-6.2% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $387K+0.5% | $386K+0.5% | $386K0.0% | $385K0.0% | $385K0.0% | ||
| $632.18M+2.0% | $628.78M+2.0% | $625.89M+2.0% | $621.19M+1.8% | $619.55M+1.8% | ||
| -$454.53M-7.4% | -$446.45M-6.6% | -$440.1M-7.9% | -$429.2M-8.6% | -$423.15M-10.8% | ||
| $2.71M+177% | $998K+127% | $61K+102% | -$2.02M+53.7% | -$3.53M-25.9% | ||
| $7.38M0.0% | $7.38M0.0% | $7.38M+17.8% | $7.38M+29.2% | $7.38M+29.2% | ||
| $173.36M-6.7% | $176.33M-5.6% | $178.86M-9.0% | $182.97M-11.0% | $185.87M-15.0% | ||
| $260.68M-8.7% | $269.68M-7.5% | $265.64M-9.5% | $280.14M-11.8% | $285.42M-12.1% | ||
| $10.5M+8.4% | $11.07M+9.6% | $9.54M-12.3% | $10.4M-8.5% | $9.68M+3.8% | ||
| $65.49M-7.7% | $66.73M-8.7% | $68.38M-9.8% | $69.12M-10.7% | $70.93M-13.0% | ||
| $10.5M+8.4% | $11.07M+9.6% | $9.54M-12.3% | $10.4M-8.5% | $9.68M+3.8% | ||
| $10.5M+8.4% | $11.07M+9.6% | $9.54M-12.3% | $10.4M-8.5% | $9.68M+3.8% | ||
| $32.3M-12.6% | $29.85M-25.2% | $27.66M-18.9% | $35.52M-13.6% | $36.95M+19.3% | ||
| $32.3M-12.6% | $29.85M-25.2% | $27.66M-18.9% | $35.52M-13.6% | $36.95M+19.3% | ||
| $4.66M-19.1% | $6.72M-25.1% | $8.74M+34.2% | $7.39M-2.5% | $5.76M-43.9% | ||
| $4.55M+8.4% | $4.33M-0.1% | $4.27M-7.7% | $4.07M-16.1% | $4.2M-29.0% | ||
| $7.9M+10.2% | $8.29M+69.0% | $6.09M+12.4% | $10.15M+71.6% | $7.17M+80.8% | ||
| —— | —— | —— | $4.07M-16.1% | —— | ||
| $632.18M+2.0% | $628.78M+2.0% | $625.89M+2.0% | $621.19M+1.8% | $619.55M+1.8% | ||
| $387K+0.5% | $386K+0.5% | $386K0.0% | $385K0.0% | $385K0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $4.55M+8.4% | $4.33M-0.1% | $4.27M-7.7% | $4.07M-16.1% | $4.2M-29.0% | ||
| —— | —— | —— | $4.07M-16.1% | —— | ||
| —— | —— | —— | $400K— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are AngioDynamics's total assets?
- AngioDynamics (ANGO) holds $260.7M in total assets, down 8.7% year over year.
- How much debt does AngioDynamics have?
- AngioDynamics carries $7.9M in total debt against $173.4M of shareholders' equity, a debt-to-equity ratio of 0.05.
- How much cash does AngioDynamics have?
- AngioDynamics holds $37.8M in cash and equivalents.
- Can AngioDynamics cover its short-term obligations?
- Its current ratio is 2.35 — current assets exceed current liabilities.
- Where does AngioDynamics's balance sheet data come from?
- Every line is extracted from AngioDynamics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
